What Perspective Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 7 | 7 |
| Sells | 7 | 7 |
| Total trades | 14 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 151,648 | 151,648 |
| Disposed | 517,889 | 517,889 |
| Net activity | −366,241 | −366,241 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Woods Lori A | Director | Nov 12 | Open-market buy · P | +23,750 | $0.84 | +$20K | 28,557 |
| Williamson Robert F Iii | Director | Nov 12 | Open-market buy · P | +6,289 | $0.84 | +$5.27K | 115,271 |
| Williamson Robert F Iii | Director | Nov 12 | Open-market buy · P | +18,609 | $0.84 | +$15.6K | 28,473 |
| Morich Frank | Director | Nov 12 | Open-market buy · P | +15,000 | $1.00 | +$15K | 15,000 |
| Puhlmann Markus | Chief Medical Officer | Nov 12 | Open-market buy · P | +35,000 | $0.84 | +$29.6K | 178,542 |
| Puhlmann Markus | Chief Medical Officer | Nov 11 | Open-market buy · P | +6,000 | $0.83 | +$4.98K | 143,542 |
| Spoor Johan M. | Chief Executive Officer | Nov 11 | Open-market buy · P | +47,000 | $0.81 | +$37.9K | 106,383 |
| Lantheus Alpha Therapy, Llc | 10% owner | Sep 04 | Open-market sale · S | −167,149 | $3.15 | −$526K | 11,273,364 |
| Lantheus Alpha Therapy, Llc | 10% owner | Sep 03 | Open-market sale · S | −80,783 | $3.11 | −$251K | 11,440,513 |
| Lantheus Alpha Therapy, Llc | 10% owner | Sep 02 | Open-market sale · S | −42,129 | $3.11 | −$131K | 11,521,296 |
| Lantheus Holdings, Inc. | 10% owner | Sep 01 | Open-market sale · S | −35,769 | $3.12 | −$112K | 11,563,425 |
| Lantheus Alpha Therapy, Llc | 10% owner | Sep 01 | Open-market sale · S | −35,769 | $3.12 | −$112K | 11,563,425 |
| Lantheus Holdings, Inc. | 10% owner | Aug 31 | Open-market sale · S | −78,145 | $3.14 | −$246K | 11,599,194 |
| Lantheus Alpha Therapy, Llc | 10% owner | Aug 31 | Open-market sale · S | −78,145 | $3.14 | −$246K | 11,599,194 |
| Hunt Jonathan Robert | Chief Accounting Officer | Nov 13 | Open-market buy · P | +11,000 | $2.03 | +$22.3K | 59,800 |
| Williamson Robert F Iii | Director | Nov 12 | Open-market buy · P | +9,498 | $2.10 | +$19.9K | 9,864 |
| Woods Lori A | Director | Mar 31 | Open-market buy · P | +23,475 | $2.13 | +$50K | 183,460 |
| Williamson Robert F Iii | Director | Mar 31 | Open-market buy · P | +38,145 | $2.14 | +$81.8K | 108,982 |
| Graham Juan | Chief Financial Officer | Mar 28 | Open-market buy · P | +33,333 | $2.25 | +$74.9K | 35,354 |
| Williamson Robert F Iii | Director | Mar 28 | Open-market buy · P | +22,192 | $2.27 | +$50.4K | 70,837 |
Loading...